EPTIS
BAM Logo

NPM1 Mutation Status

EPTIS factsheet 146067 | Last revision 2018-08-09 | URL: https://www.eptis.bam.de/pts146067 https://www.eptis.bam.de/pts146067

PT provider
PT provider UK NEQAS for Leucocyte Immunophenotyping UK NEQAS for Leucocyte Immunophenotyping
Based in United Kingdom
Language(s) English
Remarks Please refer to our website for further information: www.ukneqasli.co.uk Qualitative programme
Keywords
Product groups
Testing fields Biology
Medical analysis
Technical details
Test item Tested property Testing method
Lyophilised cell preparation NPM1 (exon 12) mutation status (presence/absence) Various molecular biology techniques for the analysis of nucleic acids (DNA/RNA)
Aims of the PT scheme
Target group of participants Participation is open to both UK and international laboratories.
Linked to specific legislation / standards ISO 17043:2010 ISO 13528:2015 ISO 15189:2012
Additional, subsidiary aims validation of testing methods
Number of participants
Accredited or otherwise reviewed by a 3rd party

Accredited by UKAS on the basis of ISO/IEC 17043

Operation is commissioned / requested by
Fees and frequency
Participation fee Please contact UKNEQASLI for details
Regularly operated Yes (3 per annum (each send-out includes 2 samples))
Year of first operation 2011
Contact details of the PT provider
Provider Contact person
UK NEQAS for Leucocyte Immunophenotyping
4th Floor, Pegasus House, 463a Glossop Road
S10 2QD Sheffield
United Kingdom

Phone: +44 (0) 114 2673600
Fax:
Web: http://www.ukneqasli.co.uk http://www.ukneqasli.co.uk
Mr Stuart Scott
Phone: +44 (0) 114 2673600
Fax:
Email: admin@ukneqasli.co.uk admin@ukneqasli.co.uk
If you find any mistakes please contact the responsible EPTIS coordinator in United Kingdom, Mr Savvas Xystouris. Mr Savvas Xystouris.
Any questions or problems? Please contact us at eptis@bam.de.
Application version: 1.23-SNAPSHOT.20230502124635-7925ae379a631fc1ececff45d2921c8db38877d5